CASI PHARMACEUTICALS, INC.

Profile

Company Names

CASI PHARMACEUTICALS, INC.

Addresses

1701-1702, CHINA CENTRAL OFFICE TOWER 1, NO. 81 JIANGUO ROAD, CHAOYANG DISTRICT, BEIJING, F4 100025

1701-1702, CHINA CENTRAL OFFICE TOWER 1, NO. 81 JIANGUO ROAD CHAOYANG DISTRICT, BEIJING, F4 100025

Phone Numbers

86 10 6561 8789
(240) 864-2600

 

Entity Type:

OTHER

Industry:

PHARMACEUTICALS

Year Incorporated:

2023

State Incorporated:

CAYMAN ISLANDS

Total Amount Raised:

$35,000,000.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2026-04-17 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
4
2026-02-19 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
3
2026-01-09 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
2
2025-12-27 
$5,000,000.00 
$5,000,000.00 
$0.00 
Debt 
1
2024-06-26 
$15,000,000.00 
$15,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID 
 
CORY 
EXECUTIVE OFFICER, DIRECTOR
EIGER BIOPHARMACEUTICALS INC   |  CASI PHARMACEUTICALS, INC.
THOMAS 
 
FOLINSBEE 
DIRECTOR
CASI PHARMACEUTICALS, INC.
WEI 
 
GAO 
EXECUTIVE OFFICER
AIRZEBRA HOLDING INC   |  CASI PHARMACEUTICALS, INC.
WEI-WU 
 
HE 
DIRECTOR, EXECUTIVE OFFICER
ENTREMED INC   |  ORIGENE TECHNOLOGIES, INC.   |  HUMAN LONGEVITY, INC.   |  CASI PHARMACEUTICALS, INC.
HAI 
 
HUANG 
EXECUTIVE OFFICER
CASI PHARMACEUTICALS, INC.
JAMES 
 
HUANG 
DIRECTOR
YAUPON THERAPEUTICS INC   |  BELLAIRE REAL ESTATE INVESTMENT TRUST   |  WORKFORCE SOFTWARE HOLDINGS, LLC   |  WINDTREE THERAPEUTICS INC /DE/   |  MYRTELLE INC.   |  HUMAN LONGEVITY, INC.   |  CASI PHARMACEUTICALS, INC.
BARBARA 
 
KREBS-POHL 
DIRECTOR
CASI PHARMACEUTICALS, INC.
KUN 
 
QIAN 
EXECUTIVE OFFICER
CASI PHARMACEUTICALS, INC.
ZHENBO 
 
SU 
DIRECTOR
CASI PHARMACEUTICALS, INC.
CHUNHUA 
 
WANG 
EXECUTIVE OFFICER
CASI PHARMACEUTICALS, INC.
ALEXANDER 
Y. 
WU 
DIRECTOR
CASI PHARMACEUTICALS, INC.
XUEBO 
 
ZENG 
DIRECTOR
CASI PHARMACEUTICALS, INC.
WEI (LARRY) 
 
ZHANG 
EXECUTIVE OFFICER
CASI PHARMACEUTICALS, INC.
ALEXANDER 
A. 
ZUKIWSKI 
EXECUTIVE OFFICER
CASI PHARMACEUTICALS, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2026-04-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2026-04-17 
2026-02-26
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2026-02-19 
2026-01-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2025-12-27 
2026-01-28
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$5,000,001 - $25,000,000 
Debt 
2026-01-09 
2024-07-15
D
Link
PHARMACEUTICALS 
PHARMACEUTICAL PREPARATIONS [2834] 
$25,000,001 - $100,000,000 
Equity 
2024-06-26 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
JEFFERIES LLC
000002347